To understand the pulse and priorities of the pharma sector (from a business, digital, and cybersecurity standpoint), Data Security Council of India (DSCI) and Deloitte India conducted discussions with large pharma companies and industry experts in India and globally. It has been extremely encouraging to see that the sector is charged up to capitalize on the next phase of growth, driven by digital transformation, with a strong focus on smart manufacturing, digital supply chain, and customer value proposition.
The joint report by DSCI and Deloitte India, ‘Indian pharma takes the digital leap: What does it mean for cybersecurity?' brings out the rapid changes that the pharma sector is witnessing, supported by digital transformation, and the way it affects their cybersecurity posture.
The report goes into the facets of digital and cybersecurity priorities of leading pharma organizations, with a spotlight on the best practices. It is further aimed at catalyzing discussions to bolster the security posture of the entire ecosystem, with a focus on the MSME sector.